Ujin Pharma Ltd.

filed drhp

Source: SEBI

DRHP26 Jun 2026completed
RHP—not yet reached
Price band—not yet reached
Opens—not yet reached
Closes—not yet reached
Allotment—not yet reached
Listing—not yet reached

Issue price

—

Issue size

—

Fresh issue

—

Offer for sale

—

What the company does

Business model: Distribution and supply of solvents, specialty chemicals, and pharmaceutical raw materials.
Revenue drivers: Substantial portion of revenue derived from distribution business.
Customers & concentration: Top 10 customers contributed 27.04% to 32.64% of revenue.

Context

What the company does

Ujin Pharma Ltd. is offering a public issue comprising a fresh issue of up to 11,869,100 equity shares and an offer for sale of up to 7,282,300 equity shares. The company has identified its promoters as Jinesh Rasiklal Sheth, Umang Ketan Mehta, and Neha Umang Mehta.

Industry opportunity

The Indian specialty chemical market is one of the fastest-growing segments within the global chemical industry, with projections indicating growth from USD 64 billion in FY 2025 to USD 91 billion by FY 2030. Demand is driven by various sectors, including pharmaceuticals and agrochemicals.